Inter-tumor heterogeneity

Mike Cusnir; Ludmila Cavalcante

doi:10.4161/hv.21203

Inter-tumor heterogeneity

Mike Cusnir, Ludmila Cavalcante

Medicine

Research output: Contribution to journal › Comment/debate › peer-review

13 Scopus citations

Abstract

Advances in the molecular study of cancer have focused on biomarkers in the setting of tumor-driving mutations within the great heterogeneity of the tumor genomic landscape. It is clearly recognized now that even two tumors originating from the same organ even if histological they appear similar their behavior and response to therapy can be different. These findings have increased interest and research to find truly prognostic and predictive biomarkers to serve as tools in better assessing the natural course of disease and response to treatments in the hope of truly individualizing cancer therapy in the future.

Original language	English (US)
Pages (from-to)	1143-1145
Number of pages	3
Journal	Human Vaccines and Immunotherapeutics
Volume	8
Issue number	8
DOIs	https://doi.org/10.4161/hv.21203
State	Published - Aug 2012

ASJC Scopus subject areas

Immunology and Allergy
Immunology
Pharmacology

Access to Document

10.4161/hv.21203

Fingerprint Dive into the research topics of 'Inter-tumor heterogeneity'. Together they form a unique fingerprint.

Cite this

@article{36c14d17ac86423780e2c2604aa10591,

title = "Inter-tumor heterogeneity",

abstract = "Advances in the molecular study of cancer have focused on biomarkers in the setting of tumor-driving mutations within the great heterogeneity of the tumor genomic landscape. It is clearly recognized now that even two tumors originating from the same organ even if histological they appear similar their behavior and response to therapy can be different. These findings have increased interest and research to find truly prognostic and predictive biomarkers to serve as tools in better assessing the natural course of disease and response to treatments in the hope of truly individualizing cancer therapy in the future.",

author = "Mike Cusnir and Ludmila Cavalcante",

year = "2012",

month = aug,

doi = "10.4161/hv.21203",

language = "English (US)",

volume = "8",

pages = "1143--1145",

journal = "Human Vaccines and Immunotherapeutics",

issn = "2164-5515",

publisher = "Landes Bioscience",

number = "8",

}

TY - JOUR

T1 - Inter-tumor heterogeneity

AU - Cusnir, Mike

AU - Cavalcante, Ludmila

PY - 2012/8

Y1 - 2012/8

N2 - Advances in the molecular study of cancer have focused on biomarkers in the setting of tumor-driving mutations within the great heterogeneity of the tumor genomic landscape. It is clearly recognized now that even two tumors originating from the same organ even if histological they appear similar their behavior and response to therapy can be different. These findings have increased interest and research to find truly prognostic and predictive biomarkers to serve as tools in better assessing the natural course of disease and response to treatments in the hope of truly individualizing cancer therapy in the future.

AB - Advances in the molecular study of cancer have focused on biomarkers in the setting of tumor-driving mutations within the great heterogeneity of the tumor genomic landscape. It is clearly recognized now that even two tumors originating from the same organ even if histological they appear similar their behavior and response to therapy can be different. These findings have increased interest and research to find truly prognostic and predictive biomarkers to serve as tools in better assessing the natural course of disease and response to treatments in the hope of truly individualizing cancer therapy in the future.

UR - http://www.scopus.com/inward/record.url?scp=84866131656&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866131656&partnerID=8YFLogxK

U2 - 10.4161/hv.21203

DO - 10.4161/hv.21203

M3 - Comment/debate

C2 - 22854659

AN - SCOPUS:84866131656

VL - 8

SP - 1143

EP - 1145

JO - Human Vaccines and Immunotherapeutics

JF - Human Vaccines and Immunotherapeutics

SN - 2164-5515

IS - 8

ER -

Inter-tumor heterogeneity

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this